TABLE I. Summary of restriction fragment length polymorphism-IS6110 (RFLP-IS6110) genotyping publications.
| States | No. of studiesa | % | % by region | No. of IS6110 | % in cluster | |
| Southeast | SP | 11 | 28.2 | 74.4 | 2 to 21 | 22 to 56 |
| ES | 5 | 12.5 | NR | 40 to 48 | ||
| RJ | 11 | 28.2 | 2 to 22 | 19 to 84b | ||
| MG | 2 | 5.1 | 1 to 18 | 6 to 25 | ||
| South | PR | 0 | 0 | 10.3 | - | - |
| SC | 0 | 0 | - | - | ||
| RS | 4 | 10.3 | 1 to 18 | 36 to 69c | ||
| Central West | GO | 2 | 5.1 | 10.3 | 1 to 14 | 0 |
| MT | 0 | 0 | - | - | ||
| MS | 2 | 5.1 | 4 to 17 | 64 to 69d | ||
| DF | 0 | 0 | - | - | ||
| North | TO | 0 | 0 | 2.6 | - | - |
| PA | 0 | 0 | - | - | ||
| AP | 0 | 0 | - | - | ||
| RR | 1 | 2.6 | NR | 30 | ||
| AM | 0 | 0 | - | - | ||
| RO | 0 | 0 | - | - | ||
| AC | 0 | 0 | - | - | ||
| Northeast | MA | 0 | 0 | 2.6 | - | - |
| PI | 0 | 0 | - | - | ||
| CE | 0 | 0 | - | - | ||
| RN | 0 | 0 | - | - | ||
| PB | 0 | 0 | - | - | ||
| PE | 0 | 0 | - | - | ||
| AL | 0 | 0 | - | - | ||
| SE | 0 | 0 | - | - | ||
| BA | 1 | 2.6 | 2 to 16 | 27 | ||
| TOTAL | 39 | 100 | 100 | 1 to 22 | 0 to 84 |
a: for these calculations, articles that analysed samples from more than one state in the same study were disregarded; b: study with inmate population; c: tuberculosis multidrug resistant (TB-MDR) population study; d: study with indigenous population; NR: not reported.